India's IPO market soars, but mega deals aren't always safe bets—research before investing in the next big IPO.

Forget weight-loss drugs and the latest development for their makers — the hottest healthcare stock right now makes those ubiquitous striped blankets for newborns and offers more than 300,000 other ...

Medline CEO Jim Boyle (R) celebrates after ringing the opening bell at Nasdaq Marketsite headquarters on Dec. 17, 2025. Photo by Michael M. Santiago/Getty Images A blockbuster IPO from an ...

After a record 2025 with 373 listings raising ₹1.95 trillion, primary market activity slows sharply as subscriptions moderate, small- and mid-cap weakness weighs on sentiment, and analysts flag a ...

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s ...

In pushing ahead with its IPO, both Medline and investors that are supporting the deal upfront are looking past the negative impact of tariffs. Only 16% of Medline’s total cost of goods sold is ...

India’s primary market is beginning to show signs of fatigue after a strong run in 2025, with the recent IPOs of Aye Finance and Clean Max Enviro Energy Solutions failing to fully subscribe, ...

Medline shares close 41% above offer price in debut Tariffs pose a challenge for Medline SpaceX, others eye 2026 listing Dec 17 (Reuters) - Medical supply giant Medline's shares rose 41% above their ...